AT&T’s Series C preferred ADS (under ticker T.PR.C) provides cumulative dividends yielding 6.26%, offering stable income backed by reliable telecom cash flows. AT&T reported strong Q1 2025 revenues ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in B Cell Medicines (BCMs), today announced the closing of its $92M Series C financing. The round includes ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics (“Aviceda”), a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity ...